A detailed history of Westfield Capital Management CO LP transactions in Merus N.V. stock. As of the latest transaction made, Westfield Capital Management CO LP holds 993,157 shares of MRUS stock, worth $44.1 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
993,157
Previous 608,457 63.23%
Holding current value
$44.1 Million
Previous $30.4 Million 37.38%
% of portfolio
0.19%
Previous 0.14%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$41.45 - $54.5 $15.9 Million - $21 Million
384,700 Added 63.23%
993,157 $41.8 Million
Q3 2024

Nov 12, 2024

BUY
$47.19 - $58.84 $28.7 Million - $35.8 Million
608,457 New
608,457 $30.4 Million

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $2.04B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Westfield Capital Management CO LP Portfolio

Follow Westfield Capital Management CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Westfield Capital Management CO LP with notifications on news.